Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tovah Day

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Journal of Biological Chemistry|August 17, 2006
The Chk1-mediated S-phase checkpoint targets initiation factor Cdc45 via a Cdc25A/Cdk2-independent mechanismPeijun Liu, Laura R Barkley, Tovah Day, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
FANCJ promotes PARP1 activity during DNA replication that is essential in BRCA1 deficient cellsKe Cong, Nathan MacGilvary, Silviana Lee, et al.
Cancer Research|June 13, 2012
BCL2 suppresses PARP1 function and nonapoptotic cell deathChaitali Dutta, Tovah Day, Nadja Kopp, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 17, 2023
Treatment of Sulfur Mustard Corneal Injury by Augmenting the DNA Damage Response (DDR): A Novel ApproachRobert Shalwitz, Tovah Day, Anna Kotsakis Ruehlmann, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Journal of Biological Chemistry|August 17, 2006
The Chk1-mediated S-phase checkpoint targets initiation factor Cdc45 via a Cdc25A/Cdk2-independent mechanismPeijun Liu, Laura R Barkley, Tovah Day, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
FANCJ promotes PARP1 activity during DNA replication that is essential in BRCA1 deficient cellsKe Cong, Nathan MacGilvary, Silviana Lee, et al.
Cancer Research|June 13, 2012
BCL2 suppresses PARP1 function and nonapoptotic cell deathChaitali Dutta, Tovah Day, Nadja Kopp, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 17, 2023
Treatment of Sulfur Mustard Corneal Injury by Augmenting the DNA Damage Response (DDR): A Novel ApproachRobert Shalwitz, Tovah Day, Anna Kotsakis Ruehlmann, et al.
Pageof 1